Info

Stocks-in-Depth

The Stocks-in-Depth podcast is provided by GARP Research, a provider of institutional equity research reports since 1995. GARP is renown for the granularity of its models and extensive written assessments of competitive threats and vulnerabilities. GARP's investment philosophy is predicated on discovering opportunity through fundamental assessment via intensive modelling, having a wide ranging curiosity about strategic influences, and engaging in person-to-person contact. GARP looks for long-term growth, but it is cognizant of finding value in contrarian situations and wants valuation to be reasonable relative to potential earnings.
RSS Feed
Stocks-in-Depth
2019
January


2018
December
November
October


2017
October
September
January


2016
December
November
October
July
June
May
April
March
February
January


2015
December
November


All Episodes
Archives
Now displaying: Page 1
Nov 28, 2015

Zeltiq has single handedly created a new market for reducing fat that targets the moderately overweight segment.  It has become the fastest growing aesthetic treatment, which was already notable for the tremendous demand for neuromodulators like Botox and hyaluronic acid fillers like Restylane and Juvaderm.  In Part 1 of this podcast, we explore how Zeltiq's high margin consumables and systems have permitted the company to break through the barriers that often restrain new aesthetic products.  We also discuss why cyrolipolysis, an affordable and non-surgical procedure, is popular with a new group of women and also men who are approaching practitioners for help in sculpting difficult areas of their bodies that they can't control with dieting or exercise alone.

0 Comments
Adding comments is not available at this time.